Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis i (MPS I)

Journal of Inherited Metabolic Disease

Volumn 36, Issue 2, 2013, Pages 257-262

  Archer, Louise D ^a   Langford Smith, Kia J ^b   Critchley, William R ^a   Bigger, Brian W ^b   Fildes, James E ^a,c  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b Stem Cell and Neurotherapies Laboratory   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD4 ANTIGEN; CD45RB ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 3 RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HELPER CELL; HURLER SYNDROME; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; RECEPTOR DOWN REGULATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; WILD TYPE; ANIMAL; C57BL MOUSE; DOWN REGULATION; IMMUNOLOGY;

ANIMALS; ANTIGENS, CD45; DENDRITIC CELLS; DOWN-REGULATION; MICE; MICE, INBRED C57BL; MUCOPOLYSACCHARIDOSIS I; RECEPTORS, INTERLEUKIN-3; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84879694126     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-012-9508-8     Document Type: Article

References (53)

1. Andersen MH, Schrama D et al (2006) Cytotoxic T cells. J Invest Dermatol 126(1):32-41
2. Annacker O, Burlen-Defranoux O et al (2000) Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment. J Immunol 164(7):3573-3580
3. Ausseil J, Desmaris N et al (2008) Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice. PLoS One 3(5):e2296
4. Beissert S, Schwarz A et al (2006) Regulatory T cells. J Invest Dermatol 126(1):15-24
5. Bossi G, Griffiths GM (1999) Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 5(1):90-96
6. Boya P, Gonzalez-Polo RA et al (2005) Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25(3):1025-1040
7. Burman C, Ktistakis NT (2010)Autophagosome formation in mammalian cells. Semin Immunopathol 32(4):397-413
8. Castaneda JA, Lim MJ et al (2008) Immune system irregularities in lysosomal storage disorders. Acta Neuropathol 115(2):159-174
9. Clark R, Kupper T (2005) Old meets new: the interaction between innate and adaptive immunity. J Invest Dermatol 125(4):629-637
10. Clarke LA, Russell CS et al (1997) Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene. Hum Mol Genet 6(4):503-511
11. Constantopoulos G, Dekaban AS (1978) Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls. J Neurochem 30(5):965-973
12. Curtsinger JM, Schmidt CS et al (1999) Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 162(6):3256-3262
13. Dahlen E, Hedlund G et al (2000) Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J Immunol 164(5):2444-2456
14. Dani A, Chaudhry A et al (2004) The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment. J Cell Sci 117(Pt 18):4219-4230
15. Davies JD, O'Connor E et al (1999) CD4+ CD45RB low-density cells from untreated mice prevent acute allograft rejection. J Immunol 163(10):5353-5357
16. de Groot RP, Coffer PJ et al (1998) Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal 10(9):619-628
17. Eskelinen EL, Saftig P (2009) Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 1793(4):664-673
18. Fleischer J, Soeth E et al (1996) Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology 89(4):592-598
19. Gimmi CD, Freeman GJ et al (1993) Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci U S A 90(14):6586-6590
20. Groux H, O'Garra A et al (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737-742
21. Guermonprez P, Valladeau J et al (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621-667
22. Hara M, Kingsley CI et al (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166(6):3789-3796
23. Harris NL, Ronchese F (1999) The role of B7 costimulation in T-cell immunity. Immunol Cell Biol 77(4):304-311
24. Holley RJ, Deligny A et al (2011) Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking alpha-l-iduronidase. J Biol Chem 286(43): 37515-24
25. Joffre O, Nolte MA et al (2009) Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 227(1):234-247
26. Johnson DE (1998) Regulation of survival pathways by IL-3 and induction of apoptosis following IL-3 withdrawal. Front Biosci 3:d313-d324
27. Lim B, Sutherland RM et al (2006) Targeting CD45RB alters T cell migration and delays viral clearance. Int Immunol 18(2):291-300
28. Luke PP, Deng JP et al (2006) Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions. Am J Transplant 6(9):2023-2034
29. Lutz MB (2004) IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4. Immunobiology 209(1-2):79-87
30. Malinowska M Wilkinson FL et al (2010) Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS One 5(12): e14192.
31. Mellman I, Steinman RM (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106(3):255-258
32. Moore D, Connock MJ et al (2008) The prevalence of and survival in Mucopolysaccharidosis I: hurler, hurler-scheie and scheie syndromes in the UK. Orphanet J Rare Dis 3:24
33. Morrissey PJ, Charrier K et al (1993) CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178(1):237-244
34. Muenzer J, Wraith JE et al (2009) Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123(1):19-29
35. Ohmi K, Greenberg DS et al (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A 100(4):1902-1907
36. Ohta T, Kinoshita T et al (1997) Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J Biol Chem 272(37):23111-23116
37. Peters PJ, Borst J et al (1991) Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173(5):1099-1109
38. Piccirillo CA, Shevach EM (2001) Cutting edge: control of CD8+ T cell activation by CD4+ CD25+ immunoregulatory cells. J Immunol 167(3):1137-1140
39. Porter AG, Janicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6(2):99-104
40. Powrie F, Carlino J et al (1996) A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 183(6):2669-2674
41. Puri N, Roche PA (2008) Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A 105(7):2580-2585
42. Russell C, Hendson G et al (1998) Murine MPS I: insights into the pathogenesis of Hurler syndrome. Clin Genet 53(5):349-361
43. Sallusto F, Geginat J et al (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745-763
44. Settembre C, Fraldi A et al (2008) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17(1):119-129
45. Shen DT, Ma JS et al (2006) Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells. J Leukoc Biol 80(4):827-837
46. Shevach EM (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30(5):636-645
47. Swain SL, Bradley LM et al (1991) Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev 123:115-144
48. Tang Q, Bluestone JA (2008) The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9(3):239-244
49. Ten Hove T, The Olle F et al (2004) Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease. J Leukoc Biol 75(6):1010-1015
50. Valenzuela J, Schmidt C et al (2002) The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J Immunol 169(12):6842-6849
51. Van Gool SW, Vermeiren J et al (1999) Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production. Eur J Immunol 29(8):2367-2375
52. Wraith JE (1995) The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child 72(3):263-267
53. Yoshimori T (2004) Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun 313(2):453-458